Peter W Schreiber

InstitutionUniversity of Zurich
AddressZurich
Switzerland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 23 publications over 7 distinct years, with a maximum of 8 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Audigé A, Böni J, Schreiber PW, Scheier T, Buonomano R, Rudiger A, Braun DL, Eich G, Keller DI, Hasse B, Berger C, Günthard HF, Manrique A, Trkola A, Huber M. Reduced Relative Sensitivity of the Elecsys SARS-CoV-2 Antigen Assay in Saliva Compared to Nasopharyngeal Swabs. Microorganisms. 2021 Aug 10; 9(8). PMID: 34442779.
      Citations:    
    2. Maximiano Sousa F, Roelens M, Fricker B, Thiabaud A, Iten A, Cusini A, Flury D, Buettcher M, Zukol F, Balmelli C, Zimmermann P, Troillet N, Vuichard-Gysin D, Schreiber PW, Bernhard-Stirnemann S, Tschudin-Sutter S, Nussbaumer-Ochsner Y, Sommerstein R, Gaudenz R, Marschall J, Senn L, Gardiol C, Keiser O, Schüpbach G, Wymann M, Vidondo B. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study. Swiss Med Wkly. 2021 07 19; 151:w20547. PMID: 34324698.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Huber M, Schreiber PW, Scheier T, Audigé A, Buonomano R, Rudiger A, Braun DL, Eich G, Keller DI, Hasse B, Böni J, Berger C, Günthard HF, Manrique A, Trkola A. High Efficacy of Saliva in Detecting SARS-CoV-2 by RT-PCR in Adults and Children. Microorganisms. 2021 Mar 19; 9(3). PMID: 33808815.
      Citations: 8     
    4. Scheier T, Shah C, Huber M, Sax H, Hasse B, Günthard HF, Trkola A, Schreiber PW. Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center. Antimicrob Resist Infect Control. 2021 03 09; 10(1):51. PMID: 33750477.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Thiabaud A, Iten A, Balmelli C, Senn L, Troillet N, Widmer A, Flury D, Schreiber PW, Vázquez M, Damonti L, Buettcher M, Vuichard-Gysin D, Kuhm C, Cusini A, Riedel T, Nussbaumer-Ochsner Y, Gaudenz R, Heininger U, Berger C, Zucol F, Bernhard-Stirnemann S, Corti N, Zimmermann P, Uka A, Niederer-Loher A, Gardiol C, Roelens M, Keiser O. Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland. Swiss Med Wkly. 2021 02 15; 151:w20475. PMID: 33638351.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    6. Tepekule B, Hauser A, Kachalov VN, Andresen S, Scheier T, Schreiber PW, Günthard HF, Kouyos RD. Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19. PLoS Comput Biol. 2021 01; 17(1):e1008609. PMID: 33513139.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Hofmaenner DA, Wendel Garcia PD, Duvnjak B, Chakrakodi B, Maier JD, Huber M, Huder J, Wolfensberger A, Schreiber PW, Schuepbach RA, Zinkernagel AS, Buehler PK, Brugger SD. Bacterial but no SARS-CoV-2 contamination after terminal disinfection of tertiary care intensive care units treating COVID-19 patients. Antimicrob Resist Infect Control. 2021 01 12; 10(1):11. PMID: 33436105.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    8. Scheier T, Schibli A, Eich G, Rüegg C, Kube F, Schmid A, Karrer U, Wolfensberger A, Sax H, Schreiber PW. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020. Emerg Infect Dis. 2021 02; 27(2):404-410. PMID: 33395382.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    9. Weissberg D, Böni J, Rampini SK, Kufner V, Zaheri M, Schreiber PW, Abela IA, Huber M, Sax H, Wolfensberger A. Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office. Antimicrob Resist Infect Control. 2020 12 02; 9(1):191. PMID: 33267855.
      Citations: 5     Fields:    Translation:Humans